50128 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondent type Form name Number of 

participants 

Number of 

responses per 

participant 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Community-based Organization Representatives-Adults.Community-based Organization 

Needs Assessment.

130 1 15/60 33 

Health Department RepresentativesAdults.Health Department Needs Assessment.70 1 15/60 18 

Total ........................................... ........................................................... ........................ ........................ ........................ 51 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–19161 Filed 9–3–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0094; NIOSH 248– 

H] 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP STAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following virtual 

meeting for the World Trade Center 

Health Program Scientific/Technical 

Advisory Committee (WTCHP STAC). A 

notice of this WTCHP STAC meeting 

has also been posted on the committee 

website at: https://www.cdc.gov/wtc/ 

stac_meeting.html. 

DATES: The meeting will be held on 

September 28, 2021 from 11:00 a.m. to 

4:00 p.m., EDT, and on September 29, 

2021 from 11:00 a.m. to 4:00 p.m., EDT. 

Written comments received by 

September 21, 2021 will be provided to 

the STAC prior to the meeting. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0094; NIOSH 248–H by mail. CDC does 

not accept comments by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Docket number CDC–2021– 

0094; NIOSH 248–H, c/o Sherri Diana, 

NIOSH Docket Office, National Institute 

for Occupational Safety and Health, 

1090 Tusculum Avenue, MS C–34, 

Cincinnati, Ohio 45226. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. Written public 

comments received by September 21, 

2021, will be provided to the WTCHP 

STAC prior to the meeting. Docket 

number CDC–2021–0094; NIOSH 248–H 

will close September 29, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Tania Carreo ́n-Valencia, Ph.D., 

Designated Federal Officer, World Trade 

Center Health Program, National 

Institute for Occupational Safety and 

Health, CDC, 1600 Clifton Road, NE, MS 

R–12, Atlanta, GA 30329–4027, 

Telephone: (513) 841–4515; Email: wtcstac@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The WTCHP STAC was 

established by Title I of the James 

Zadroga 9/11 Health and Compensation 

Act of 2010, Public Law 111–347 

(January 2, 2011), amended by Public 

Law 114–113 (Dec. 18, 2015) and Public 

Law 116–59 (Sept. 27, 2019), adding 

Title XXXIII to the Public Health 

Service (PHS) Act (codified at 42 U.S.C. 

300mm to 300mm-61). 

Purpose: The purpose of the WTCHP 

STAC is to review scientific and 

medical evidence and to make 

recommendations to the Administrator 

of the World Trade Center (WTC) Health 

Program regarding additional WTC 

Health Program eligibility criteria, 

potential additions to the List of WTCRelated Health Conditions, and research 

regarding certain health conditions 

related to the September 11, 2001, 

terrorist attacks. 

Title XXXIII of the PHS Act 

established the WTC Health Program 

within the Department of Health and 

Human Services (HHS). The WTC 

Health Program provides medical 

monitoring and treatment benefits to 

eligible firefighters and related 

personnel, law enforcement officers, 

and rescue, recovery, and cleanup 

workers who responded to the 

September 11, 2001, terrorist attacks in 

New York City, at the Pentagon, and in 

Shanksville, Pennsylvania (responders), 

and to eligible persons who were 

present in the dust or dust cloud on 

September 11, 2001 or who worked, 

resided, or attended school, childcare, 

or adult daycare in the New York City 

disaster area (survivors). Certain specific 

activities of the Administrator of the 

WTC Health Program are reserved to the 

Secretary, HHS, to delegate at his 

discretion; other duties not explicitly 

reserved to the Secretary, HHS, are 

assigned to the Director of the National 

Institute for Occupational Safety and 

Health (NIOSH). The administration of 

the WTCHP STAC is left to the Director 

of NIOSH in his role as Administrator. 

CDC and NIOSH provide funding, 

staffing, and administrative support 

services for the WTCHP STAC. The 

charter was reissued on May 12, 2021 

and will expire on May 12, 2023. 

Matters to be Considered: The agenda 

will include an overview of the 

Program’s research activities in the past 

10 years and discussion of the 

Administrator’s request that the STAC 

provide a recommendation regarding 

whether to add uterine cancer to the List 

of health conditions eligible for 

coverage by the WTC Health Program. A 

white paper on scientific considerations 

developed to assist the Committee in 

their deliberations is available on the 

WTC Health Program website at https:// 

www.cdc.gov/wtc/stac_meeting.html. 

An agenda is also posted on the WTC 

Health Program website at https://

www.cdc.gov/wtc/stac_meeting.html. 

Agenda items are subject to change as 

priorities dictate. Meeting Information: 

This is a virtual meeting conducted via 

Zoom. The public is welcome to follow 

the proceedings via live webcast on the 

World Wide Web. No registration is 

required. The webcast link for 

September 28–29, 2021 is https://

www.ustream.tv/channel/ 

QyXBRzYjVCS. For additional 

information please visit the WTC Health 

Program website at https://

www.cdc.gov/wtc/stac_meeting.html. 

Public Participation 

Interested parties may participate in 

this activity by submitting written 

views, opinions, recommendations, and 


sradovich on DSKJLST7X2PROD with NOTICES
Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 50129 

data. You may submit comments on any 

topic related to this activity. Comments 

received, including attachments and 

other supporting materials, are part of 

the public record and subject to public 

disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

CDC does not accept comment by email. 

Oral Public Comment: The public is 

welcome to participate, via Zoom, 

during the public comment periods on 

September 28, 2021, from 11:30 a.m. to 

12:00 p.m., EDT, and on September 29, 

2021, from 12:10 p.m. to 12:40 p.m., 

EDT. Please note that the public 

comment periods end at the times 

indicated above. Each commenter will 

be provided up to five minutes for 

comment. A limited number of time 

slots are available and will be assigned 

on a first come-first served basis. 

Members of the public who wish to 

address the WTCHP STAC during the 

oral public comment sessions must sign 

up by providing their name and desired 

date for commenting to Mia Wallace, 

Committee Management Specialist, via 

email: MWallace@cdc.gov, or the 

addresses section provided in this 

notice by September 21, 2021. 

Written Public Comment: Written 

comments will also be accepted from 

those unable to attend the public 

session per the instructions provided in 

the addresses section above. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. Written 

comments received by September 21, 

2021 will be provided to the STAC prior 

to the meeting. The docket will close on 

September 29, 2021. 

Policy on Redaction of Committee 

Meeting Transcripts (Public Comment): 

Transcripts will be prepared and posted 

to http://www.regulations.gov within 60 

days after the meeting. If a person 

making a comment gives their name, no 

attempt will be made to redact that 

name. NIOSH will take reasonable steps 

to ensure that individuals making 

public comments are aware that their 

comments (including their name, if 

provided) will appear in a transcript of 

the meeting posted on a public website. 

Such reasonable steps include a 

statement read at the start of the meeting 

stating that transcripts will be posted, 

and names of speakers will not be 

redacted. If individuals in making a 

statement reveal personal information 

(e.g., medical information) about 

themselves, that information will not 

usually be redacted. The CDC Freedom 

of Information Act coordinator will, 

however, review such revelations in 

accordance with the Freedom of 

Information Act and, if deemed 

appropriate, will redact such 

information. Disclosures of information 

concerning third party medical 

information will be redacted. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–19224 Filed 9–3–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Membership on the Lead Exposure and 

Prevention Advisory Committee 

(LEPAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is 

soliciting nominations for membership 

on the LEPAC. The LEPAC is composed 

of 15 members that are Federal and nonFederal experts in fields associated with 

lead screening, the prevention of lead 

exposure, and services for individuals 

and communities affected by lead 

exposure. Nominations are being sought 

for individuals with expertise in the 

fields of epidemiology, toxicology, 

mental health, pediatrics, early 

childhood education, special education, 

diet and nutrition, and environmental 

health. Members may be invited to serve 

for three-year terms. Selection of 

members is based on candidates’ 

qualifications to contribute to the 

accomplishment of LEPAC objectives. 

DATES: Nominations for membership on 

the LEPAC must be received no later 

than November 1, 2021. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

emailed to LEPAC@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: Paul 

Allwood, Ph.D., M.P.H., Designated 

Federal Officer, National Center for 

Environmental Health, CDC, 4770 

Buford Highway NE, Atlanta, GA 

30329–4018, Telephone: (770) 488– 

6774, PAllwood@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

members of this committee are selected 

by the Secretary of the U.S. Department 

of Health and Human Services (HHS). 

The committee’s objective is to advise 

the Secretary, HHS and the Director, 

Centers for Disease Control and 

Prevention/Administrator, Agency for 

Toxic Substances and Disease Registry 

on a range of activities to include: (1) 

Review of Federal programs and 

services available to individuals and 

communities exposed to lead; (2) review 

of the current research on lead exposure 

to identify additional research needs;(3) 

review of and identification of best 

practices, or the need for best practices 

regarding lead screening and the 

prevention of lead exposure; (4) 

identification of effective services, 

including services relating to healthcare, 

education, and nutrition for individuals 

and communities affected by lead 

exposure and lead poisoning, including 

in consultation with, as appropriate, the 

lead exposure registry as established in 

Public Law 114–322 Section 2203(b) (42 

U.S.C. 300j-27); and (5) undertaking of 

any other review or activities that the 

Secretary determines to be appropriate. 

Annually as determined necessary by 

the Secretary or as required by Congress, 

the committee shall submit a report to 

include: (1) An evaluation of the 

effectiveness of the Federal programs 

and services available to individuals 

and communities exposed to lead; (2) an 

evaluation of additional lead exposure 

research needs; (3) an assessment of any 

effective screening methods or best 

practices used or developed to prevent 

or screen for lead exposure; (4) input 

and recommendations for improved 

access to effective services relating to 

health care, education, or nutrition for 

individuals and communities impacted 

by lead exposure; and (5) any other 

recommendations for communities 


sradovich on DSKJLST7X2PROD with NOTICES